Back to AQST
CITADEL ADVISORS LLC AQST Position History
Aquestive Therapeutics, Inc. • Healthcare
Quarters held
15
Latest value
$900K
Q3 2026
Peak value
$2.8M
First seen
Q1 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2026 | $1.4M |
| Q1 2026 | $2.3M |
| Q1 2026 | $523K |
| Q2 2026 | $524K |
| Q2 2026 | $804K |
| Q2 2026 | $1.4M |
| Q2 2026 | $272K |
| Q2 2026 | $524K |
| Q2 2026 | $804K |
| Q2 2026 | $1.4M |
| Q2 2026 | $272K |
| Q3 2026 | $998K |
| Q3 2026 | $433K |
| Q3 2026 | $2.8M |
| Q3 2026 | $900K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $900K | 194.3K | — | — |
| Q3 2026 | $2.8M | 594.2K | — | — |
| Q3 2026 | $433K | 93.5K | — | — |
| Q3 2026 | $998K | 215.6K | — | — |
| Q2 2026 | $272K | 65.5K | — | — |
| Q2 2026 | $1.4M | 326.3K | — | — |
| Q2 2026 | $804K | 193.2K | — | — |
| Q2 2026 | $524K | 125.9K | — | — |
| Q2 2026 | $272K | 65.5K | — | — |
| Q2 2026 | $1.4M | 326.3K | — | — |
| Q2 2026 | $804K | 193.2K | — | — |
| Q2 2026 | $524K | 125.9K | — | — |
| Q1 2026 | $523K | 126.1K | — | — |
| Q1 2026 | $2.3M | 565.2K | — | — |
| Q1 2026 | $1.4M | 328.2K | — | — |